any pivotal trials have demonstrated that the sirolimus-eluting stent (SES) has significantly decreased the rate of restenosis and the need for recurrent intervention compared with bare metal stents (BMS). 1, 2 In the real world, the SES is used for more complex lesions and favorable results have been achieved for percutaneous coronary intervention (PCI), especially a reduction in the need for revascularization. [3] [4] [5] [6] [7] Coronary artery disease (CAD) is now the main cause of death in women. 8 The Women's Ischemia Syndrome Evaluation (WISE) Study demonstrated that women, especially older women, are particularly at risk of increased morbidity and mortality. [9] [10] [11] Other studies evaluating the outcome of PCI have also reported higher rates of mortality and major complications in women compared with men. [12] [13] [14] [15] [16] Therefore, it is possible that the poor outcome of PCI in elderly women is related to the development of severe atherosclerotic changes, probably because of clustering of coronary risk factors. However, there is a lack of data regarding the characteristics and prognosis in elderly women with CAD, and it remains unknown whether SES reduces the major adverse cardiovascular events (MACE) and improves the prognosis in this particular population.
Coronary Angiography and Quantitative Analysis
Selective coronary angiography was performed in multiple projections after administration of intracoronary nitroglycerin (0.125-0.25 mg). The angiographic characteristics of CAD were evaluated by computer-assisted quantitative analysis (CMS-QCA ver. 4.0, Medis, Leiden, The Netherlands), as reported previously. 19 Briefly, we measured the diameter of the middle section in each major coronary segment (segments 1-3 of the right coronary artery, segments 6-8 of the left anterior descending artery, and segments 11 and 13 of the left circumflex artery) in order to calculate the average vessel diameter (AVD) for each patient. We defined segments with an irregular edge that narrowed to a diameter ≤1.5 mm as diseased lesions and calculated the average lesion length (ALL). In a previous study, lumen diameter <1.5 mm was related with sufficient sensitivity and specificity to fractional flow reserve <0.75, a level highly inducive to causing myocardial ischemia. 20 The far distal portions of segments 8 and 13 that had a smooth and regular edge were not included in the ALL measurements. The QCA data were assessed by an experienced cardiologist (I. M.) who was unaware of the patients' status.
PCI Procedure
All procedural decisions, including device selection and adjunctive pharmacotherapy, were made at the discretion of the individual PCI operator. Intravenous heparin (5,000 IU) and intracoronary nitroglycerin (0.5 mg) were administered before PCI. After stent implantation, angiographic optimization was performed by high-pressure dilatation to achieve an acceptable angiographic result. Intravascular ultrasound was used according to the operator's decision. Procedural success was defined as residual stenosis <20% without major complications. All patients received 324 mg/day of aspirin for at least 24 h before the procedure. Dual antiplatelet therapy (aspirin 300 mg and ticlopidine 200 mg) was given to all patients treated with BMS for 2 weeks and in those treated with SES for at 3-12 months. For the assessment of restenosis, exercise test or stress scintigraphy was routinely performed at 6-8 months after PCI. If myocardial ischemia was noted in this initial non-invasive testing, follow-up coronary angiography was performed.
The 
Clinical Parameters and Follow-up
All the patients underwent assessment of coronary risk factors, angiography, and laboratory analyses including fasting glucose, hemoglobin A1c (HbA1c), total cholesterol (TC), triglycerides (TG), high-density lipoprotein-cholesterol-(HDL-C), low-density lipoprotein-cholesterol (LDL-C) and creatinine levels. Body mass index (BMI) was calculated as weight (kg)/height (m) 2 .
Follow-up information was obtained at the outpatient's clinic or by a review of the medical records. Follow-up was completed for all patients (100%). The primary endpoint was defined as all-cause mortality, and the secondary endpoint was the occurrence of the MACE, which included all-cause death, non-fatal myocardial infarction (MI), heart failure (HF) and target lesion revascularization (TLR) related to PCI procedure and occurring in the follow-up period.
HF was diagnosed if a patient showed signs of exertional dyspnea, orthopnea, rales in more than one-third of the lung fields, elevated jugular venous pressure or pulmonary congestion on chest X-ray related to cardiac dysfunction. MI was defined as 2 or more of the following: (1) typical chest pain >20 min duration not relieved by nitroglycerin; (2) serial ECG recordings showing changes from baseline in ST-T and/or Q-waves in 2 or more contiguous leads; (3) elevation of serum creatine kinase >2-fold of normal. TLR was defined as repeat PCI or coronary bypass surgery, performed because of restenosis or a new stenotic lesion in the target vessel. Definite and possible stent thrombosis were defined on the basis of the Academic Research Consortium stent thrombosis classification. 21 Complete revascularization (CR) on QCA was defined as a residual stenosis <20% in the 3 major coronary arteries and their major branches (branch diameter >2 mm).
The clinical and angiographic characteristics and the incidence of MACE were compared among the 4 groups in the BMS and SES eras using the chi-square test (or Fisher's exact test) for categorical data, or analysis of variance (ANOVA) was performed for continuous data. For univariate analysis, the following clinical variables and risk factors were regarded as covariates: age, gender, glycemic status (fasting glucose and HbA1c level), lipid profiles (TC, TG, HDL-C, LDL-C), creatinine level, BMI and the use of cardiovascular medications. On the basis of the results of univariate analysis, multivariate logistic regression analysis was performed to investigate the independent predictors of small AVD (<3.0 mm) and long ALL (>20 mm). Event-free survival was estimated using the Kaplan-Meier method, and differences were assessed using the log-rank test. A P value <0.05 was considered to be statistically significant. All analyses were performed using Stat-View software, version 5.0 (SAS Institute Inc, Cary, NC, USA). Table 1 shows the baseline characteristics of the 4 groups in the BMS era: 406 men <75 years old, 132 men ≥75 years old, 65 women <75 years old, and 67 women ≥75 years old. Compared with men ≥75 years old, women ≥75 years old had higher levels of fasting blood glucose, HbA1c, TC and LDL-C, lower levels of hemoglobin, and higher prevalence of smoking. A higher prevalence of peripheral vascular disease was seen in women ≥75 years old compared with women <75 years old. Furthermore, among the 4 groups, the prevalence of previous MI and 3-vessel disease was the highest in women ≥75 years old. There were no significant differences in the medical treatment of groups except for aspirin use. 80 (20) 40 (31) 16 (24) 21 (31) Serum creatinine ≥177 μmol/l, n (%)
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QCA in the BMS Era
The results of QCA in the BMS era are summarized in Figure 2a . The AVD in women ≥75 years old was statistically significantly smaller than that in men ≥75 years old or <75 years old. ALL in women ≥75 years old was 13.8± 10.1 mm, which was not statistically significantly different from the other groups.
To investigate the independent predictors of small AVD (<3.0 mm) and long ALL (>20 mm), we performed univariate and multivariate logistic regression analysis (Table 2) . Univariate analysis showed that hypercholesterolemia, TG, fasting blood glucose and women ≥75 years old were significant predictors for small AVD. By multivariate analysis, all of these variables were independent predictors of small AVD. Regarding long ALL, TG, HDL-C, fasting blood glucose, hypertension and women ≥75 years old were significant predictors by univariate analysis. Multivariate analysis revealed that HDL-C and women ≥75 years old were strong independent predictors for long ALL.
MACE in the BMS Era
The event-free survival curve of the BMS era is shown in Figure 3 . During the follow-up period of 75 months (median), women ≥75 years old had the highest incidence of cardiovascular events among the 4 groups. In particular, the incidence of TLR was high (55%), and the occurrence of death and HF was 11% and 25%, respectively, which were significantly higher in women ≥75 years old compared with other 3 groups. The prevalence of restenosis was 43% in elderly women with MACE.
Baseline Characteristics in the SES Era
Baseline characteristics of patients in the SES era are summarized in Table 3 . The 4 groups consisted of 450 men <75 years old, 145 men ≥75 years old, 57 women <75 years old, and 52 women ≥75 years old. Overall, the patients' demographics were similar in the BMS era and the SES era, except for the prevalence of unstable angina pectoris and previous MI. When comparing elderly women in the BMS era and those in the SES era, their characteristics were similar except for the prevalence of unstable angina pectoris and peripheral vascular disease and the use of angiotensinreceptor blockers. Figure 2b shows the results of QCA in the SES era. Although AVD was comparable between the 2 eras, ALL in the SES era (31.9±10.2 mm) was approximately 3-fold longer than that in the BMS era. In the SES era, smaller AVD and longer ALL were observed in women ≥75 years old, compared with women <75 years old and men ≥75 years old.
QCA in the SES Era
MACE in the SES Era
During the follow-up period of 34 months (median) in the SES era, there were no significant differences in MACE among the 4 groups (Figure 3 ). The incidence of TLR was low (3%) in women ≥75 years old.
As shown in Figure 4 , the incidence of all-cause death and cardiac death in women ≥75 years old in the SES era was significantly lower than that of the BMS era. In detail, 9 patients died from: sepsis (n=1), cerebral bleeding (n=3), HF (n=3) and sudden death (n=2) in the BMS era, whereas no patients died in the SES era.
To clarify the role of CR, we compared the occurrence of MACE among the 4 groups, elderly women with and without CR in the BMS era (n=35 and 32, respectively) and those with and without CR in the SES era (n=34 and 18, respectively). As shown in Figure 5 , there were no significant differences between patients with and without CR in the BMS era. In the SES era, patients with CR had a lower occurrence of MACE than patients without CR.
Discussion
In the present study, elderly women (women ≥75 years old) who underwent PCI had angiographically smaller and longer coronary atherosclerotic lesions than men and women aged <75 years old. Although there was a high prevalence of MACE in this particular population in the BMS era, the use of SES in the current era reduced the occurrence of MACE, primarily by reducing all-cause death and TLR.
Morphological Characteristics of CAD in Elderly Women
Sharaf et al using severity scores to describe the advanced and diffuse atherosclerotic changes in 323 women with CAD. 22 This score assesses the severity of a diseased lesion by its percentage diameter stenosis; however, that method can underestimate the severity of stenosis, particularly in patients with diffuse coronary narrowing, because it is difficult to identify a normal reference segment on angiography. Therefore, we used QCA to assess the whole coronary tree in a large population (n=1,374). As reported previously, QCA is more accurate, objective and reproducible than manual caliper measurements. 19, 23, 24 The parameters we used (ie, AVD and ALL) enabled us to evaluate in detail the absolute values for the entire coronary tree, and our QCA analysis revealed that severe atherosclerotic changes had developed in women ≥75 years old (Figures 2,4) . In addition, the morphological characteristics of CAD were more severe in the SES era than in the BMS era, because the ALL was >30 mm on average. We previously reported that morphological changes such as small vessels and diffuse narrowing developed in patients with diabetes mellitus or impaired glucose tolerance. 19 As shown in Table 1 , women ≥75 years old had higher fasting glucose and HbA1c levels than similar aged men. Additionally, glucose metabolism, represented by the fasting glucose level, was a significant determinant for small vessels and diffuse coronary narrowing (Table 2) . Therefore, elderly women (≥75 years old) may have a high prevalence of abnormal glucose tolerance than other patients and this metabolic abnormality seems to be an important factor in the development of severe coronary atherosclerotic changes (Table 2 ). 
Improved Prognosis of Elderly Women With CAD in the SES Era
In the BMS population of the present study there was a high incidence of MACE in women ≥75 years old. Small vessel size and long lesion length were associated with development of restenosis in the BMS era, 25, 26 and we found a strikingly high rate of TLR in women ≥75 years old in the present study. Because of the higher risk of developing restenosis, the benefit of CR on long-term prognosis might be traded off, as shown in Figure 5 . The incidence of death and HF in women ≥75 years old were also higher than in other groups.
Many recent studies have demonstrated that SES strongly inhibit neointimal hyperplasia and reduce the need for TLR. 1,2 SES can be used in complex lesions that seemed unsuitable for PCI in the BMS era. [3] [4] [5] [6] [7] Considering the greater efficacy of SES and their increased use in lesions that were unsuitable for PCI in women ≥75 years old (eg, ALL >30 mm on average), it can be proposed that the improved clinical outcomes, including all-cause and cardiac death, might be related to a reduction in ischemic events, which has resulted from the low restenosis rates associated with the use of SES. In addition, the reduction in ischemic events may prevent HF and arrhythmias.
Study Limitations
There are some biases and differences in patient selection for this retrospective study; for example, the difference between the BMS and SES eras for lesion length in elderly women may reflect a change in the indication for PCI. However, the general policy and procedure of PCI performed at our institution did not change from 1 era to the next. Moreover, the increased usage of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and statins should be taken into consideration as modifiers of the results. Although the prevalence of unstable angina differed between the BMS and SES era, an unstable clinical presentation did not exert a significant impact on outcome as reported in previous studies. [27] [28] [29] 
Conclusions
Elderly women with CAD have particular characteristics of coronary atherosclerosis, such as small vessels and diffuse coronary narrowing, which could be related to abnormal glucose tolerance and/or dyslipidemia. In the BMS era, this particular patient group had the worst long-term prognosis compared with men or women <75 years old. However, in the SES era, this difference in prognosis has been alleviated, mainly because of a reduction in all-cause death and TLR.
